Citation Impact
Citing Papers
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Cancer treatment and survivorship statistics, 2022
2022 Standout
Coronavirus biology and replication: implications for SARS-CoV-2
2020 Standout
COVID-19 infection: the China and Italy perspectives
2020
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
2020
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Midwifery and quality care: findings from a new evidence-informed framework for maternal and newborn care
2014 Standout
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
2016
The immunology of COVID-19: is immune modulation an option for treatment?
2020
Hodgkin lymphoma: 2018 update on diagnosis, risk‐stratification, and management
2018
Inhaled analgesia for pain management in labour
2012
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020
2020 Standout
Works of Tycel Phillips being referenced
Comparative Effect of Pethidine, Trichloroethylene, and Entonox on Fetal and Neonatal Acid-Base and Po 2
1971
Delayed response in ipilimumab therapy
2014
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial
2019
A phase 1 study of INCB040093, a PI3Kδ inhibitor, alone or in combination with INCB039110, a selective JAK1 inhibitor: Interim results from patients (pts) with relapsed or refractory (r/r) classical Hodgkin lymphoma (cHL).
2015